[1]
|
Cervera, R., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., Mejía, J.C., Aydintug, A.O., Chwa- linska-Sadowska, H., de Ramón, E., Fernández-Nebro, A., Galeazzi, M., Valen, M., Mathieu, A., Houssiau, F., Caro, N., Alba, P., Ramos-Casals, M., Ingelmo, M. and Hughes, G.R. (2003) European working party on systemic lupus erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period. A comparison of early and late matifestation in a cohort of 1, 000 patients. M
|
[2]
|
Uramoto, K.M., Michet, C.J., Thumboo, J. Sunku, J., O’Fallon, W.N. and Gabriel, S.E. (1999) Trends in the incidence and mortality of systemic lupus erytemathosus, 1950-1992. Arthritis & Rheumatism, 42(1), 46-50.
|
[3]
|
Pons-Estel, B.A., Catoggio, L.J., Cardiel, M.H., Soriano, E.R., Gentiletti, S., Villa, A.R., Abadi, I., Caeiro, F., Alvarellos, A. and Alarcón-Segovia, D. (2004) Grupo latinoamericano de estudio del lupus. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythe- matosus: Ethnic and disease heterogeneity among ‘His- panics’, Medicine (Baltimore), 83(1), 1-17.
|
[4]
|
Boddaert, J., Huong, D.L., Amoura, Z., Wechsler, B., Godeau, P. and Piette, J.C. (2003) Late-onset systemic lupus erythematosus. A personal series of 4 patients and pooled analisis of 714 cases in the literature. Medicine (Baltimore), 83(6), 348-359.
|
[5]
|
Karlson, E.W., Daltroy, L.H., Lew, R.A., Wright, E.A., Partridge, A.J., Fossel, A.H., Roberts, W.N., Stern, S.H., Straaton, K.V., Wacholtz, M.C., Kavanaugh, A.F., Grosflam, J.M. and Liang, M.H. (1997) The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis & Rheumatism, 40(1), 47-56.
|
[6]
|
To, C.H., Mok, C.C., Tang, S.S., Ying, S.K., Wong, R.W. and Lau, C.S. (2009) Prognostically distinct clinical patterns of systemic lupus erythematosus identified by cluster analysis. Lupus, 18(14), 1267-1275.
|
[7]
|
Bach, J.F., Koutouzow, S. and van Endert, P.M. (1998) Are there unigue autoantigents triggering autoimmune diseases? Immunological Reviews, 164(1), 139-155.
|
[8]
|
Kurien, B.T. and Scofield, R.H. (2006) Autoantibody determination in the diagnosis of systemic lupus eryth- ematosus. Scandinavian Journal of Immunology, 64(3), 227-235.
|
[9]
|
Nezlin, R., Alarcyn-Segovia, D. and Shoenfeld, Y. (1998) Immuno-chemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus. Journal of Autoimmunity, 11(5), 489-493.
|
[10]
|
Schett, G., Smole, J., Zimmermann, C., Hiesberger, H., Hoefler, E., Fournel, S., Muller, S., Rubin, R.L. and Steiner, G. (2002) The autoimmune response to chromatin antigens in systemic lupus erythematosus: Autoantibodies against histone Н1 are a highly specific marker for SLE associated with increased disease activity. Lupus, 11(11), 704-715.
|
[11]
|
Gabibov, A.V. Ponomarenko, N.A., Tretyak, E.B., et al. (2006) Catalic autoantibodies in clinical autoimmunity and modern medicine. Autoimmunity Reviews, 5(5), 324-330.
|
[12]
|
Gabibov, A.G., Kozyr, A.V., Kolesnikov, A.V. and Suchkov, S.V. (2000) Disease association and cytotoxic effects of DNA-hydrolyzing autoantibodies. Chemical Immunology, 77, 130-156.
|
[13]
|
Kozyr, A.V. and Gabibov, A.G. (2009) DNA-hydro- lyzing AB: is catalytic activity a clue for physiological significance? Autoimmunity, 42(4), 359-361.
|
[14]
|
Kit, I., Mahorivs’ka, I.R., Havryliuk, A.M., Chhop’iak, V.V., Bily?, R.O. and Sto?ka, R.S. (2009) Proteolytic activity of blood serum IgG in patients with systemic lupus erythematosis. Ukr Biokhim Zh., 81(3), 77-83.
|
[15]
|
Kit, Y.Y., Starykovich, M.A., Richter, V. A. and Stoika, R.S. (2008) Detection and characterization of IgG- and sIgA-Abzymes capable of hydrolyzing Histone H1. Biochemistry (Moscow), 73(8), 950-956.
|
[16]
|
Magorivska, I., Bilyy, R., Shalay, O., Loginsky, V., Kit, Y. and Stoika, R. (2009) Blood serum immunoglobulings of patients with multiple myeloma are capable of hy- drolizing histone H1. Experimental Oncology, 31(2), 97-101.
|
[17]
|
Magorivska, I.B., Bilyy, R.O., Havrylyuk, A.M., Chop’- yak, V.V., Stoika, R.S. and Kit, Y.Y. (2010) Anti-histone H1 IgGs from blood serum of systemic lupus erythe- matosus patients are capable of hydrolyzing histone H1 and myelin basic protein. Journal of Molecular Recog- nization, 23(5), 495-502.
|
[18]
|
Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259), 680-685.
|